The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination
The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination
Recruiting · NCT03878706 · Registry updated 2026-03-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Not stated | 2026-03-13 | NCT03878706 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Athens | 18 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| "Attikon" University General Hospital | Athens | Greece | 3 |